Drug Class
IL-6 receptor antagonist
Type
brand
Active Ingredient
satralizumab
📋Overview
Enspryng is a medication used to help manage certain autoimmune conditions that affect the central nervous system. It is most commonly associated with neuromyelitis optica spectrum disorder (NMOSD), a rare disorder that causes inflammation of the optic nerves and spinal cord. Enspryng works by targeting specific proteins involved in the immune response, aiming to reduce disease activity. Its use is generally reserved for individuals with specific antibody profiles linked to NMOSD.
📚References
Information from MedlinePlus.gov (NIH).
Found an Error?
Help us keep this information accurate. If you notice any incorrect details, please submit a correction request.
Find Discounts for Enspryng
Hospitals.net Disclosure
Hospitals.net is an independent healthcare information platform and does not provide, administer, or guarantee prescription discounts, pricing, coupons, or pharmacy participation. All discount pricing and availability shown above are provided by RxGo and its partners and are subject to change without notice.
Hospitals.net may receive a commission or referral fee if you choose to use this prescription discount service. This does not affect the price you pay at the pharmacy. Hospitals.net is not responsible for pricing accuracy, pharmacy participation, or the fulfillment of any discount offers.